Introduction
Rheumatoid arthritis (RA) has a prevalence of 1-2% and is one of the common causes of morbidity among people over 65 years of age (Gabriel, 2001) . It is characterized by hyperplasia of fibroblast-like synovial cells (FLS) within the synovium and recruitment of multiple leukocyte populations that drive the inflammatory process (Hardy et al., 2013) . Although disease etiology is unknown, it is thought that both genetic and environmental factors in which genes have been influence such as medical illnesses and factors in the external environment such as pollution can trigger the onset of RA (Smolen and Aletaha, 2009 ). RA synovial fibroblasts represent a unique cell type that distinguishes RA from other inflammatory conditions of the joints. Proinflammatory mediators including tumor necrosis factor alpha (TNFα) and interleukin 1 beta (IL1β) are produced by macrophage cells, T-cells and B-cells to promote synoviocyte cell proliferation including the release of matrix-degrading enzymes with the induction of pro-angiogenic factors and secretion of cytokines and chemokines (Tak and Bresnihan, 2000) . Synovial hyperplasia is mediated by these pro-inflammatory cytokines resulting in chronic inflammation and tissue destruction in RA. In response to these cytokines, FLS produce chemokines and adhesion molecules that further promote inflammation, hyperplasia, and cartilage destruction (Honda et al., 2006; Choy and Panayi, 2001) .
Binding of tumor necrosis factor alpha (TNFα) to vascular adhesion molecule 1 (VCAM-1) and intracellular adhesion molecule 1(ICAM-1) in synovial fibroblasts activates the inflammatory response, which is critical in the recruitment of immune cells to affected joints (Umar et al., 2015) . As a part of the synovial tissue reaction, proliferating synovial cells penetrate the cartilage in the form of a pannus. The mechanisms responsible for pannus formation are not fully understood, however synovial hyperplasia and formation into the pannus is the fundamental pathogenesis of RA (Choy and Panayi, 2001 ) Previous studies have established that TNFα is a critical effector in the pro-inflammatory cytokine cascade in RA (Ntougkos et al., 2017; Hardy et al., 2013; Feldmann et al., 1996) that induces production of pro-inflammatory mediators, such as prostaglandin E 2 (PGE 2 ), a cyclooxygenase 2 (COX-2) metabolite that sensitizes nociceptors and promote an inflammatory response within the joint (Goel et al., 2003) .
Nuclear factor-kappaB (NF-κB) is an important transcription factor that regulates expression of inflammatory gene, including COX-2 (Karin, 2009 ). Activation of NF-κB by various stimuli, including cytokines (TNFα) and lipopolysaccharide (LPS), results in nuclear translocation of the p65/p50 subunit and transactivation of numerous inflammatory cytokines and adhesion molecules (De Miranda et al., 2015; Lawrence, 2009) . Inhibition of this pathway by knockdown of IκB kinase (IKK) can reduce inflammatory gene expression in models of tissue injuiry (Acharyya et al., 2007) but pharmacological inhibitors of this pathway have proven difficult to translate to clinical applications. The orphan nuclear receptor, NR4A2 (Nurr1) has emerged as an important endogenous regulator of NF-κB and modulates the expression of inflammatory cytokines and chemokines in diseases characterized by prolonged or inappropriate inflammatory responses, such as RA (Bonta et al., 2006; Holla et al., 2006; McEvoy et al., 2002; Mix et al., 2007) . Unlike most nuclear receptors, the NR4A family are rapidly activated by inflammatory mediators, suggesting their respective receptors may act as potential transcriptional mediators of cytokine signaling (Bonta et al., 2006; Holla et al., 2006; McEvoy et al., 2002; Mix et al., 2007) . In RA, joint tissues produce markedly increased levels of NR4A2 compared to other NR4A family members (McEvoy et al., 2002; Mix et al., 2007) . NR4A2 is encoded within an immediate early gene that is rapidly induced in cells in response to external stimuli such as cytokines. Microarray analysis has established that over-expression of NR4A2 (Nurr1) in K4 IM synoviocytes inhibits the expression of pro-inflammatory genes, including IL-8 (Davies et al., 2005) .
In this study, we investigated one of a novel series of paraphenyl substituted dinndolylmethane compounds (C-DIMs) that has been previously demonstrated to be a transcriptional modulator of NR4A family nuclear receptors (De Miranda et al., 2015; Lee et al., 2014; Yoon et al., 2011; Inamoto et al., 2008) . C-DIM12 activates Nurr1 in dopaminergic neurons , microglial cells (De Miranda et al.,2015) , pancreatic cells (Li et al., 2012) and in urothelial carcinoma cells (Inamoto et al., 2008) . However, it is unknown whether C-DIM12 directly inhibits inflammatory gene transcription in primary synovial fibroblasts. Therefore, in this study we postulate that C-DIM12 inhibits inflammatory signaling in primary synovial fibroblasts by a Nurr1-dependent mechanism. The data presented here provides evidence that C-DIM12 suppresses adhesion molecules and pro-inflammatory cytokines in synovial fibroblasts after stimulation with tumor necrosis factor (TNFα). C-DIM12 induces Nurr1 expression resulting in suppression of TNFα-induced inflammatory cytokine secretion, by a nuclear-specific mechanism. These results provide a novel mechanism for suppression of inflammation within synovial fibroblasts and therefore pose a new possibility for therapeutic intervention aimed at reducing synovial tissue destruction in RA.
Materials and methods

Reagents
C-DIM12 was synthesized as described by Qin et al. (2004) . All general chemical reagents were purchased from Sigma, Aldrich (St. Louis, MO) unless stated otherwise. TNFα was purchased from R&D Systems (Minneapolis, MN). Specific primary antibodies against VCAM-1(55330), ICAM-1 (553253), Mac-1(Cd11b) (553310), CD90.2 (553011), COX-2 (610204) were purchased from BD Biosciences (San Jose, CA), antibodies against Nurr1 (SC-376984) and NF-κB p65 (SC-8008) were purchased from Santa Cruz Biotechnology (Dallas, TX), antibody against Vimentin (AB1620) was purchased from EMD Millipore (Burlington, MA), and Iκβα (4814) was purchased from Cell Signaling Technology (Danvers, MA).
Primary cell isolation
Primary synovial fibroblasts were isolated from the talocrural joint of wild type (WT) C57BL/6 6-8-week-old mice according to procedures described by Armaka et al., 2009 and purity was confirmed through FACS and immunofluorescent staining using antibodies against CD90.2, Cd11b, VCAM-1, ICAM-1 and vimentin. In brief, 6-8-week-old mice were euthanized using carbon dioxide, hind legs were rapidly dissected out with the foot intact. Tissue was subjected to digestion with collagenase from Clostridium hitolyticum type IV (1 mg/ml). This method routinely results in cultures that are approximately 99% pure synovial fibroblasts with less than 1% contaminating macrophage cells (Fig. 1) . Synovial fibroblast cultures were maintained in Dulbecco's modified Eagle's media supplemented with 10% FBS, and 1xPSN. The cells were maintained at 37°C with 5% CO 2. Synovial fibroblasts were used up to passage 3 of plating. All procedures involving animals were approved by the Colorado State University Institutional Animal Care and Use committee and were conducted in accordance with current National Institutes of Health guidelines.
RNA interference
RNA interference (siRNA/RNAi, small interfering RNA) sequences were obtained through Integrated DNA technologies (IDT DNA, Coralville, IA). Nurr1 RNAi duplexes were designed against splice common variants of Nurr1 and validated using a dose response assay with increasing concentrations of the suspended oligo (1.2 μg) using a standard scrambled dicer-substrate RNA as control. RNAi oligos were transfected using the TransIT-X2 delivery system (Mirus Bio, Madison, WI) for 24 h (Fig. 6a) . Separate siRNA systems were used to ensure specific knockdown of Nurr1 mRNA. The Nurr1 DsiRNA duplex sequences (5′-> 3′) CUAGGUUGAAGAUGUUAUAGGCACT; AGUGCCUA UAACAUCUUCAACCUAGAA (IDT DsiRNA, denoted RNAi).
Gene expression
Nurr1 mRNA expression upon knockdown was assessed by quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR). Briefly, RNA was isolated using the RNEasy Mini kit (Qiagen, Valencia, CA). Purity and concentration were determined using a Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). RNA (250-1000 ng) was then used as template for reverse transcriptase (RT) reactions using the iScript RT kit (BioRad, Hercules CA). cDNA was immediately profiled for Nurr1 gene expression (forward: 5′-GTG TTCAGGCGCAGTATGG-3′; reverse: 5′-TGGCAGTAATTTCAGTGTT GGT-3′) using HPRT as a housekeeping gene (forward: 5′-TCAGTCAA CGGGGGACATAAA-3′; reverse: 5′-GGGGCTGTACTGCTTAACCAG-3′) according to the 2-ΔΔCT method (Livak and Schmittgen, 2001 ). 
Enzyme-linked immunosorbent assay
Primary synovial fibroblasts were pre-treated for an hour with or without 10 μM C-DIM12 followed by 10 ng/ml TNFα for 12 h prior to harvesting conditioned media. The conditioned media was preserved with 1% BHT solution to avoid the free-radical peroxidation as explained in by Cao et al., 2008 . Samples were stored at −20°C until analysis. PGE 2 analysis and quantification was conducted via ELISA using a PGE 2 analysis kit (R&D Systems) in accordance with the manufacturer's instructions, except samples were not diluted as indicated. The experiment was conducted three independent experiment runs in triplicate.
Immunofluorescence protein expression and translocation
Synovial Fibroblasts (5 × 10 4 cells/ per coverslip) were plated on cover glass (preconditioned with FBS) and allowed to adhere for 18 h. Cells were then pretreated for 1 h with 10 μM C-DIM12 followed by 10 ng/ml TNFα for 30 min. Cells were washed with PBS buffer and fixed with 4% paraformaldehyde for 10 min at 4°C. Cells were blocked using bovine serum albumin (Sigma-Aldrich) for 1 h at room temperature followed by incubation with primary antibodies overnight at 4°C. Secondary antibody incubation was at room temperature for 2 h with Alexa Flour 555 (Life technologies) and DAPI counterstain (Vector Laboratories, Burlingame, CA). Slides were imaged using a Zeiss Axiovert 200 M inverted fluorescence microscope equipped with a Hammamatsu ORCA-ER-cooled charge-coupled device camera (Hammamatsu Photonics, Hamamatsu City, Japan) using slidebook software (version 5.5, Intelligent Imaging Innovation, Denver, CO). Total nuclear protein was quantified by fluorescence intensity of NF-κB p65 or Nurr1 within the nuclear region of the cell, as determined by DAPI counterstain. Slidebook 5.0 software generated fluorescence intensity minus background and six to eight microscopic fields were examined per treatment group, with at least 3 biological replicates (coverslips) per treatment group, over no less than three independent experiments. Fluorescent secondary antibodies were used to detect phalloidan (excitation at 488 nm; emission at 519 nm) and NF-κB p65 or Nurr1 (excitation at 555 nm; emission at 565 nm), respectively, whereas mounting medium contain 4,6-diamidino-2-phenlindole (excitation at 358 nm; emission at 461 nm) was used to identify cell nuclei.
Fluorescence-activated cell sorting (FACS) analysis
Synovial fibroblasts (3 × 10 5 per well) were plated in 6 well plates and allowed to adhere for 18 h. The cells were then pretreated with for 1 h. with 10 μM C-DIM12 followed by 10 ng/ml TNFα for 12 h. The cells were then harvested and fixed with 2% paraformaldehyde for 10 min. Cells membranes were permeabilized with 0.01% triton X-100 in PBS for 30 min. and stained with antibodies against NF-κB p65, COX-2, Nurr1 and IκBα for 1 h. at 37°C. Secondary incubation was at 37°C for 1 h. with Alexa flour 647. Unstained cells were used as negative controls during acquisition. Flow cytometry was conducted on a Beckman Coulter CyAn ADP flow cytometer operating with Summit v4.3 software for data collection. All further analysis was done with FlowJo (version 10.0.8; Software, Ashland, OR). Samples were run in biological triplicates with two technical duplicates.
2.8. Cytokine/chemokine determination in cell culture supernatants by cytometric bead array (CBA)
Supernatant was collected and immediately processed for Interleukin-6 (IL-6), interleukin-10 (IL-10), monocyte Chemoattractant protein-1 (MCP-1), and interferon-γ (IFN-γ) protein levels were quantitatively measured by BD CBA Mouse Inflammation Kit (BD Biosciences, San Jose, CA). The protocol was performed according to the manufacturer's instructions. The intensity of fluorescence signal was acquired on a Beckman Coulter CyAn ADP Flow cytometry operating with Summit v4.3 software for data collection. All further analysis was done with FlowJo (version 10.0.8; Software, Ashland, OR). Samples were run in biological triplicates with two technical duplicates.
Statistical analysis
Statistical analyses were performed using Prism (version 7.0; Graph Pad Software, San Diego, CA). Data are presented as mean ± S.E.M. Experimental group analyses were performed using a one-way analysis of variance with a Tukey post hoc test. *P < 0.05, ** P < 0.01, ***P < 0.001, **** P < 0.0001 were considered statistically significant.
Results
Purity of primary cultured synovial fibroblasts was determined by FACS three passages after plating (Fig. 1) . Cells were stained for constitutive expression of CD90.2, VCAM-1 and ICAM-1 to confirm SF phenotype (Fig. 1a-f ). CD90.2 was > 80-90% of the cell population, whereas Cd11b, a monocyte marker, was < 1% of the population, indicating that primary cultures were comprised primarily of SF cells ( Fig. 1a and b) . Expression of the cell adhesion molecules VCAM-1 and ICAM-1 was evaluated by FACS, with representative scatter plots and histograms showing positive expression for both cell surface markers ( Fig. 1c and f) , confirming the purity of the murine synovial fibroblasts isolation. Immunofluorescence imaging confirmed expression of Vimentin, a mesenchymal marker (Fig. 1g) .
Treatment with 10 ng/ml TNFα caused both dose-and time-dependent increases in expression of VCAM-1 in synovial fibroblasts by 6 h that peaked at 12 h and remained elevated up to 48 h (Fig. 2a) . Based on the data in Fig. 2 a and b , we selected treatment with 10 ng/ ml TNFα for 12 h to be optimal, as expression of VCAM-1 was nearly as saturated as with 100 ng/ml. Co-treatment of SF cells with C-DIM12 (10 μM) effectively suppressed VCAM-1 and ICAM-1 expression after treatment for 12 h. (Fig. 2c-d) . In cells treated with C-DIM12 (10 μM) alone, there was no difference in VCAM-1 and ICAM-1 expression ( Fig. 2c-d) , and expression was similar to basal levels.
Exposure of synovial fibroblasts to TNFα (0.1-100 ng/ml) increased production of PGE 2 in a dose-dependent manner (Fig. 3) , with the highest levels of PGE 2 detected at 100 ng/ml TNFα following 24-hr exposure (Fig. 3a) . To assess the effect of C-DIM12 on PGE 2 production, we exposed synovial fibroblasts to TNFα in the absence or presence of C-DIM12. C-DIM12 alone didn't not regulate PGE 2 production. Cotreatment with C-DIM12 significantly reduced TNFα induced PGE 2 production ( Fig. 3b) and therefore we also examined the effect of C-DIM12 on TNFα-induced expression of COX-2 by FACS. Low expression of COX-2 protein was observed in resting synovial fibroblasts and COX-2 was highly induced in the presence of TNFα, and with C-DIM12 (10 μM) alone, there was no difference in COX-2 protein expression this was similar to untreated control cells ( Fig. 3c and d) . C-DIM12 significantly inhibited induced COX-2 expression comparable to basal levels detected in control synovial fibroblasts (Fig. 3c and d) .
To examine the mechanism by which C-DIM12 inhibited TNF-induced inflammatory gene expression in synovial fibroblasts, we assessed total levels of IκBα and p65 (NF-κB). Flow cytometry analysis revealed that IκBα protein expression decreased significantly following treatment with C-DIM12 (Fig. 4a-b) . Protein expression of TNF-stimulated synovial fibroblasts was analyzed for expression of p65 using flow cytometry and demonstrated a marked increase in p65 protein levels following
To determine whether C-DIM12 inhibits inflammatory protein expression by inhibiting nuclear translocation of NF-κB (p65), cells were stimulated with 10 ng/ml TNFα in the presence and absence of C-DIM12 (10 μM). In untreated cells, p65 was predominantly localized to the cytoplasm (Fig. 5a-b) and cells stimulated with TNFα demonstrated an increase in nuclear translocation of p65 ( Fig. 5a-b) . C-DIM12 (10 μM) did not prevent nuclear translocation of p65 in cells stimulated with TNFα (Fig. 5a-b) . In cells treated with C-DIM12 (10 μM) alone, there was no nuclear translocation of p65 (Fig. 5a-b) , and this was similar to untreated control cells. To investigate the effect of C-DIM12 protein expression of Nurr1, cells were also stimulated with TNFα in the presence and absence of C-DIM12. In untreated cells, Nurr1 was predominately localized to the cytoplasm (Fig. 5c-d) . In cells stimulated with TNFα, there was a marked increase in nuclear localization of Nurr1, which was further enhanced by co-treatment with C-DIM12 Fig. 2 . TNFα induced VCAM-1 and ICAM-1 expression in synovial fibroblasts. (a) TNFα dose-response of VCAM-1 expression was determined to be most optimal at 12 h (b) Primary synovial fibroblasts were cultured in a dose dependent manner with TNFα (10 ng/ml) for 12 h r. VCAM-1 surface expression was determined by FACS, as described in Methods. TNFα-induced (c) VCAM-1 and (d) I-CAM1 expression is decreased upon C-DIM12 treatment. Data are expressed as mean ± S.E.M (n = 4). Statistical significance is compared with saline control. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Fig. 3 . C-DIM12 Decreases Inflammatory PGE 2 and COX-2 Expression in Synovial Fibroblasts. (a) PGE2 dose response determined after 24 h of TNFα (10 ng/ ml) stimulation (b) Upon TNFα (10 ng/ml) exposure, PGE2 expression is increased and effectively suppressed upon 10 μM C-DIM12 treatment. (c) Overlaid histogram showing COX-2 expression in stimulated synovial fibroblast fluorescence intensity shifted to the right increase COX-and followed by treatment of C-DIM12 (10 μM) decrease back to basal condition. (d) Synovial fibroblasts were stimulated with TNFα (10 ng/ml) treated with 10 μM CDIM12 analyzed for COX-2 expression. Data are expressed as mean ± S.E.M (n = 4). Statistical significance is compared with saline control. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (Fig. 5d) . In cells treated with C-DIM12 (10 μM) alone, there was a similar increase in nuclear Nurr1 compared to control cells (Fig. 5d) .
We used RNAi to examine whether the anti-inflammatory effects of C-DIM12 on NF-κB regulated inflammatory genes were Nurr1-dependent (Fig. 6 ). Upon transfection of synovial fibroblasts with siRNA directed against Nurr1 (1.2 u g), levels of Nurr1 mRNA were reduced by approximately 70% (Fig. 6a) . Following Nurr1 knock-down, synovial fibroblasts were treated with TNFα for 24 h and then assayed via flow cytometry, to measure Nurr1 protein expression, was significantly decreased (Fig. 6b ) and after treatment with C-DIM12, synovial fibroblasts were further analyzed for expression of NF-κB regulated inflammatory genes, IL-6, MCP-1, IL-10 and IFN-γ. The results show that suppression of TNFα-induced expression of IL-6, MCP-1, IL-10 and IFN-γ (Fig. 6c-f ) by C-DIM12 was lost after knockdown of Nurr1 demonstrating a role for this receptor and its ligand in treatment of RA.
Discussion
RA is an inflammatory disease where the pathology is both triggered and sustained by the influx of expression of cytokines, which are responsible for the destruction of the joint (Li et al., 2000) . Pro-inflammatory cytokines that are overexpressed in RA joints are shown to induce a variety of disease genes, including other cytokines, proteases, cyclooxygenases and adhesion molecules, in addition to stimulating cell proliferation (Shi et al., 2004 and Feldmann et al., 1996) . The pro-inflammatory cytokine, TNFα, has been extensively researched because of its involvement in the pathogenesis of RA. TNFα mediates the cellular infiltration of the joint while the development of the pannus occurs following cytokine released by mononuclear cells (including lymphocytes and monocytes), which prompt the synovial membrane's blood vessels to multiply. This ultimately causes an increased blood flow leading to excessive tissue growth of the synovial cells resulting in the thickening of the synovium. The inflammatory process is further exacerbated by release of soluble forms of the adhesion molecules, VCAM-1 and ICAM-1 (Hideshima et al., 2002) . Thus, the signaling pathway involved in the induction of VCAM-1 by TNFα in primary synovial fibroblasts is a potential target for alternative therapeutics.
Fibroblast-like synoviocytes have been shown to play a central role in mediating inflammatory damage to joints during the progression of RA (Angiolilli et al., 2016) . To study RA progression, researchers have often utilized human FLS isolated from synovial tissue from patients undergoing joint arthroplasty (Mix et al., 2007) , however fewer studies have modeled joint disease using murine cells. In the present study, we successfully isolated FLS from C57BL/6 mice and characterized the cellular response to inflammatory stimulation with TNFα in order to model the molecular signaling that occurs during RA. Cells were characterized based upon multiple criteria including general fibroblast markers such as VCAM-1, ICAM-1, CD90.2, vimentin and Cd11b (Armaka et al., 2009 ). Alone, CD90.2 stains numerous cell types including subsets of fibroblasts, thymocyte populations, epithelial cells and neurons (Rege and Hagood, 2006) . By contrast, CD11b has been shown to be a selective marker for inflammatory cells such as macrophages and microglia. Evaluation of synovial fibroblast purity by flow cytometry revealed > 80-90 % CD90.2 positive, whereas < 1% CD11b positive (Fig. 1b) . Negative control (Fig. 1a) and compensation was taken into consideration when defining positive populations. Further FACs analysis of adhesion molecules constitutively expressed on synovial fibroblasts cell surface were evaluated 96% positive for VCAM-1 (Fig. 1c and d) and 87% positive ICAM-1 (Fig. 1e and f) . Finally, vimentin (Fig. 1g) confirmation by immunofluorescence confirmed the purity of the synovial fibroblast isolation.
Enhanced Nurr1 expression in the synovial lining layer, synovial fibroblasts of inflamed synovial tissue, confirms that Nurr1 is expressed primarily in cells believed to be the leading edge of invasive tumor-like synovium (pannus) (Ralph et al., 2005) . Primary synovial fibroblasts expressed VCAM-1 and responded to TNFα in a time and dose dependent manner, peak activity at 12-hour stimulation with 10 ng/ml TNFα stimulation (Fig. 2a and b) . Dose-dependent inhibition of adhesion Fig. 4 . C-DIM12 decrease IκBα and p65 NF-κB Expression in Synovial Fibroblasts. (a and c) The dose response of IκBα and NF-κB expression was determined 30 min. after TNFα (10 ng/ml). (b and d) synovial fibroblasts were stimulated with TNFα (10 ng/ml) treated with 10 μM CDIM12 analyzed by flow cytometry. Data are expressed as mean ± S.E.M (n = 4). Statistical significance is compared with saline control. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. molecules VCAM-1 and ICAM-1 in synovial fibroblasts indicate that C-DIM12 blocks expression of the TNFα-induced inflammatory response ( Fig. 2c and d) .
The progression of rheumatoid arthritis depends on the activation of a complex signaling network of cytokines and adhesion molecules. Previous studies have shown C-DIM12 activates Nurr1 in dopaminergic neurons , in microglia cells (De Miranda et al., 2015) , in pancreatic cells (Li et al., 2012) and in urothelial carcinoma cells (Inamoto et al., 2008 ). Here we demonstrate that C-DIM12 suppresses NF-κB-induced gene expression in synovial fibroblasts through a mechanism involving transcriptional upregulation of Nurr1, as well as enhanced nuclear localization of the receptor. This is consistent with Fig. 5 . C-DIM12 does not prevent p65 translocation and promotes Nurr1 sequestration in the nuclei of TNFα-induced primary synovial fibroblast cells. Primary synovial fibroblasts were treated with 10 μm C-DIM12 for 1 h followed by saline or 10 ng/ml of TNFα for 30 min. and fixed for immunofluorescence to examine p65 and Nurr1 translocation with DAPI(blue), phalloidan (green), p65 (red). (a-b) Representative images and quantification of p65 nuclear expression was quantified by mean fluorescence intensity encompassing the nuclei (DAPI boundary; background subtracted), demonstrating increased nuclear p65 upon TNFα with or without C-DIM12(c-d). Representative images and quantification of Nurr1 expression following TNFα and C-DIM12 treatment showed increased Nurr1 protein translocation from the cytoplasm to the nucleus. Data are expressed as mean ± S.E.M. (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. previous studies demonstrating that C-DIM12 inhibits NF-κB-induced gene expression in macrophages by stabilizing nuclear co-repressor proteins on NF-κB cis-acting elements in the promoters of inflammatory genes such as inducible nitric oxide synthase (iNOS/NOS2) (De Miranda et al., 2015) . ELISA data revealed that stimulation of primary synovial fibroblasts with TNFα induced production of PGE 2 in a dosedependent manner (Fig. 3a) . C-DIM12 suppressed PGE2 production and COX-2 expression in TNFα-stimulated synovial fibroblasts (Fig. 3b-d) and also suppressed protein expression of the NF-κB pathway proteins, p65 and IκBα ( Fig. 4a and b) . Despite the moderate decrease in levels of IκBα, the commensurately greater decrease in p65 protein expression suggests that C-DIM12 broadly suppresses the NF-κB pathway at a transcriptional level. Given that both p65/RelA and IκBα are gene targets of NF-κB, C-DIM12 likely inhibits transcription of both p65 and IκBα at NF-κB-responsive 5′ cis elements by stabilizing nuclear co-repressor protein complexes, similar to previous reports in macrophages (De Miranda et al., 2015) .
Phosphorylation and degradation of IκBα following phosphorylation by IKK leads to nuclear translocation of p65 and transcriptional activation of target genes. The observed increase in nuclear p65 after treatment with TNFα + C-DIM12 (Fig. 5a ) suggests a mechanism involving increased association between Nurr1 bound to p65, as reported in macrophages following stimulation with LPS (Saijo et al., 2009) . Given a recent report that C-DIM12 is predicted to bind with high affinity to the co-activator site of the Nurr1 ligand binding domain and also activates a Nurr1 reporter construct in neural cells (Hammond et al., 2018) , these data also suggest that C-DIM12 directly activates Nurr1 in synovial fibroblasts to inhibit NF-κB. Furthermore, immunofluorescence confirmed that C-DIM12 did not prevent TNFα-induced translocation of p65 ( Fig. 5a and b) suggesting a nuclear-specific mechanism. Therefore, we performed quantitative immunofluorescence to investigate nuclear Nurr1 recruitment by C-DIM12. As predicted, localization of Nurr1 changes upon stimulation with TNFα (Fig. 5c ), however nuclear Nurr1 was significantly increased upon TNFα + C-DIM12 treatment and C-DIM12 treatment alone (Fig. 5d) .
Moreover, knockdown of Nurr1 by RNAi significantly decreased the ability of C-DIM12 to inhibit protein expression for multiple inflammatory cytokines (Fig. 6a-f ). Nurr1 RNAi enhanced protein expression of the NF-κB-regulated inflammatory cytokines, IL-6 and MCP-1 (Fig. 6c and d) . Inhibition of inflammatory cytokines in primary Fig. 6 . C-DIM12-dependent inhibition of inflammatory gene expression requires Nurr1. (a) Synovial fibroblasts were treated with concentrations of siRNA (denoted RNAi) or scrambled RNAi (control RNAi) demonstrating 1.2 u g to be optimal. Synovial fibroblasts were transfected with Nurr1 RNAi or control RNAi for 24 h followed by saline or 10 ng/ml TNFα with or without C-DIM12 for 24 h and assessed for Nurr1 expression via flow cytometry. (b) Nurr1 was effectively knockeddown at a protein level, even in the presence of TNFα. (c-f) IL-6, MCP-1, IL-10 and IFN-γ protein expression upon knock-down and treatment was assessed via flow cytometry demonstrating a loss of C-DIM12-mediated suppression upon Nurr1 knock-down. Data are expressed as mean ± S.E.M (n = 4). Statistical significance is compared with saline control. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. synovial fibroblasts indicates that C-DIM12 blocks expression of NF-κB regulated inflammatory cytokines and chemokines. RNAi studies (Fig. 6) show that C-DIM12 does not suppress TNFα-induced expression of IL-10 and IFNγ to the same level as the other cytokines assayed, however complete suppression is lost upon knockdown. These data support that C-DIM12 requires Nurr1 to suppress pro-inflammatory gene expression in TNFα-induced synovial fibroblasts.
Expression of IL-10 and IFN-γ in synovial fibroblasts is also regulated by Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathways in addition to NF-κB (Dey et al., 2016) . However, the studies in Fig. 6 indicated that knockdown of Nurr1 expression significantly decreased the inhibitory effects of C-DIM12 on TNFα-induced expression of IL-10 and IFN-γ, suggesting that both NF-κB and JAK/STAT pathways regulate the expression of these inflammatory proteins in synovial fibroblasts following stimulation of tumor necrosis factor receptor (TNFR). Nevertheless, the efficacy of Nurr1 RNAi in preventing the inhibitory effects of C-DIM12 on these inflammatory mediators indicates that NF-κB remains an important pathway for their transcriptional activation in synovial fibroblasts in response to stimulation with TNFα.
It remains a challenge to find small molecule therapies that can reduce inflammatory joint injury in RA. Nurr1 has previously been shown to act as a NF-κB signaling following stimulation with multiple inflammatory mediators (McEvoy et al., 2002) . The data presented here demonstrate that the substituted diindolylmethane compound, C-DIM12, suppresses NF-κB signaling in synovial fibroblasts by a nuclearspecific mechanism and subsequently decreases the expression of several inflammatory cytokines, chemokines and cellular adhesion molecules in response to treatment with TNF. This anti-inflammatory activity occurs through a Nurr1-dependent mechanism, as evidenced by the efficacy of RNAi directed against Nurr1 in ablating the inhibitory effects of C-DIM12. Pharmacological modulation of inflammation in the joint with C-DIM12 may therefore represent a novel mechanism decrease expression of NF-κB regulated inflammatory genes in synovial fibroblast cells and is relevant to the mechanism of pathology in this inflammatory joint disease.
